Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Metastases”

1,777 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,777 results

Not applicableLooking for participantsNCT04854213
What this trial is testing

PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)

Who this might be right for
Colorectal Cancer Metastatic
National Cancer Institute, Naples 25
Testing effectiveness (Phase 2)Looking for participantsNCT06401824
What this trial is testing

Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases

Who this might be right for
NSCLC Stage IVBrain Metastases, Adult
Maastricht University Medical Center 25
Testing effectiveness (Phase 2)Study completedNCT03665285
What this trial is testing

A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid TumorsLung CancerBreast Cancer+6 more
NextCure, Inc. 109
Not applicableStudy completedNCT03595813
What this trial is testing

Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy

Who this might be right for
Lung Cancer MetastaticLocally Advanced Malignant NeoplasmNon Hodgkin Lymphoma+1 more
Institut Paoli-Calmettes 135
Not applicableLooking for participantsNCT05746325
What this trial is testing

Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Malignant Neoplasm in the Leptomeninges+2 more
Mayo Clinic 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT05585320
What this trial is testing

A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorPancreatic AdenocarcinomaMalignant Melanoma (Cutaneous)+1 more
Immuneering Corporation 209
Not applicableStudy completedNCT02066103
What this trial is testing

Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients

Who this might be right for
Malignant Airway Obstruction Secondary to Non-small Cell Lung Cancer
Mercator MedSystems, Inc. 20
Not applicableStudy completedNCT02846103
What this trial is testing

Study of Anti-telomerase T CD4 Immunity in Metastatic Lung Cancer

Who this might be right for
Lung Cancer
Centre Hospitalier Universitaire de Besancon 321
Not applicableStudy completedNCT02006966
What this trial is testing

The Impact of Intraoperative Systemic Lidocaine Infusion on Chronic Postoperative Pain After Video-assisted Thoracic Surgery (VATS)

Who this might be right for
Lung Cancer(Primary, Metastatic)Benign Lung Mass Requiring Operation
Yonsei University 168
Not applicableStudy completedNCT02942901
What this trial is testing

Clinical Evaluation of PET-CT for Staging of Colorectal Lung Metastases

Who this might be right for
Metastatic Colorectal Cancer
Lung Clinic Heckeshorn 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04699188
What this trial is testing

Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

Who this might be right for
KRAS G12C Mutant Solid TumorsCarcinoma, Non-Small-Cell LungCarcinoma, Colorectal+7 more
Novartis Pharmaceuticals 344
Early research (Phase 1)Study completedNCT00738751
What this trial is testing

Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers

Who this might be right for
Lung CancerHead and Neck Cancer
H. Lee Moffitt Cancer Center and Research Institute 44
Testing effectiveness (Phase 2)Study completedNCT02705820
What this trial is testing

Switch Maintenance Pembrolizumab in Patients With NSCLC After First Line Platinum Doublet Chemotherapy

Who this might be right for
Metastatic Non Small Cell Lung Cancer
Bank of Cyprus Oncology Centre 48
Testing effectiveness (Phase 2)UnknownNCT06339242
What this trial is testing

Furmonertinib Combined With Chemotherapy in the Treatment of NSCLC With Leptomeningeal Metastasis

Who this might be right for
NSCLC
Jiangsu Province Nanjing Brain Hospital 30
Early research (Phase 1)Study completedNCT00946673
What this trial is testing

Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Brain CancerNeoplasm MetastasisLung Cancer+1 more
Stanford University 17
Early research (Phase 1)Looking for participantsNCT06083870
What this trial is testing

An Early Stage Study to Evaluate Oba01 for Injection in Patients With DR5 Positive LA/mNSCLC

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Lu Shun 35
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Not applicableLooking for participantsNCT07143045
What this trial is testing

A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases

Who this might be right for
EGFR Mutant Advanced Non-small Cell Lung CancerCentral Nervous System (CNS) Metastases
Alpha Biopharma (Jiangsu) Co., Ltd. 800
Not applicableApproved For MarketingNCT04100694
What this trial is testing

Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor

Who this might be right for
NRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more
Merus B.V.
Testing effectiveness (Phase 2)WithdrawnNCT04889066
What this trial is testing

Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain Metastases

Who this might be right for
Brain Metastases from Non-small Cell Lung Cancer
University of Texas Southwestern Medical Center
Load More Results